Kennedy Capital Management, Inc. Chemo Centryx, Inc. Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $13,856 - $32,375	-625 Reduced 1.42%	43,399 $2.24 Million
Q2 2022 Aug 10, 2022	SELL	$15.36 - $27.51 $5,882 - $10,536	-383 Reduced 0.86%	44,024 $1.09 Million
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $534,902 - $941,735	-24,073 Reduced 35.15%	44,407 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $151,157 - $333,072	-8,224 Reduced 10.72%	68,480 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $1.01 Million - $1.52 Million	76,704 New	76,704 $1.31 Million
Q1 2021 May 14, 2021	SELL	$49.53 - $68.4 $1.22 Million - $1.68 Million	-24,562 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $11,387 - $15,703	-241 Reduced 0.97%	24,562 $1.52 Million
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $8,991 - $11,967	-194 Reduced 0.78%	24,803 $1.36 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $1,041 - $1,756	27 Added 0.11%	24,997 $1.44 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $817,268 - $1.27 Million	24,970 New	24,970 $1 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.